Jinkebo
Latest round
- Series A
Last raised
- Dec 2025
Total raised
- Undisclosed
Investors
- 3
About Jinkebo
, trading as Jinkebo is a gene therapy product developer that develops gene therapy research and development platforms, including the construction and optimization of viral vectors, the development of large-scale cell culture and virus production processes, quality control platforms, and preclinical validation. The company provides gene therapy products. The company's revenue is generated by providing gene therapy products.
Who invested in Jinkebo
3 investors across 1 round
See all investors in Jinkebo
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 1, 2025
Amount
Undisclosed
Investors
Questions about Jinkebo
Who invested in Jinkebo?
Jinkebo has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Jinkebo raised?
Jinkebo has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Jinkebo last raise money?
Jinkebo's most recent round on record is a Series A, in Dec 2025.
What does Jinkebo do?
, trading as Jinkebo is a gene therapy product developer that develops gene therapy research and development platforms, including the construction and optimization of viral vectors, the development of large-scale cell culture and virus production processes, quality control platforms, and preclinical validation.
Where is Jinkebo headquartered?
Jinkebo is headquartered in Shanghai, China.
Which VCs invest in companies like Jinkebo?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Jinkebo's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Jinkebo? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.